Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
Additionally, the company made the full commercial launch of the system with G7 compatibility in the United States and rolled out the Omnipod 5 App through a limited market release for iPhone. These significant developments reflect Insulet's efforts to make its ground-breaking diabetes technology available to more people globally. More on the Latest Achievements Omnipod 5 is currently eligible for people aged two years and above with Type 1 diabetes. The tubeless AID system communicates with a continuous glucose monitor (CGM), proactively correcting for highs and protecting against lows — day and night. Compatible with Dexcom G6 CGM, Omnipod 5 recently received reimbursement status from the French National Authority for Health (Haute Autorité de Santé or HAS). Following the latest expansion, the system is now available to most of the company's European customers. Furthermore, Omnipod 5 with Dexcom G7 compatibility is now commercially available in the United States. The new Omn
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years [Yahoo! Finance]Yahoo! Finance
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $236.00 to $269.00. They now have a "buy" rating on the stock.MarketBeat
- Global Insulin Pump Market Size to Reach USD 13.37 Billion by 2032, with 8.36% CAGR – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Piper Sandler from $230.00 to $285.00. They now have an "overweight" rating on the stock.MarketBeat
- A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD) [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 8/8/24 - Miss
PODD
Sec Filings
- 9/12/24 - Form 4
- 9/11/24 - Form 4
- 9/11/24 - Form 144
- PODD's page on the SEC website